Otizm Genetiği

Sivalingam AM. Advances in understanding biomarkers and treating neurological diseases-Role of the cerebellar dysfunction and emerging therapies. Ageing Res Rev. 2024;101:102519. doi: 10.1016/j.arr.2024.102519.

Romanovsky E, Choudhary A, Peles D, et al. Uncovering convergence and divergence between autism and schizophrenia using genomic tools and patients' neurons. Mol Psychiatry. 2025;30(3):1019-1028. doi: 10.1038/s41380-024-02740-0.

Lord C, Elsabbagh M, Baird G, Veenstra-Vanderweele J. Autism spectrum disorder. Lancet. 2018;392(10146):508-520. doi: 10.1016/S0140-6736(18)31129-2.

Martinez B, Peplow PV. Autism spectrum disorder: difficulties in diagnosis and microRNA biomarkers. Neural Regen Res. 2025;20(10):2776-2786. doi: 10.4103/NRR.NRR-D-24-00712.

Zeidan J, Fombonne E, Scorah J, et al. Global prevalence of autism: A systematic review update. Autism Res. 2022;15(5):778-790. doi: 10.1002/aur.2696.

Mendes M, Chen DZ, Engchuan W, et al. Chromosome X-wide common variant association study in autism spectrum disorder. Am J Hum Genet. 2025;112(1):135-153. doi: 10.1016/j.ajhg.2024.11.008.

Maenner MJ, Warren Z, Williams AR, et al. Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2020. MMWR Surveill Summ. 2023;72(2):1-14. doi: 10.15585/mmwr.ss7202a1.

Lai MC, Baron-Cohen S. Identifying the lost generation of adults with autism spectrum conditions. Lancet Psychiatry. 2015;2(11):1013-27. doi: 10.1016/S2215-0366(15)00277-1.

Zhang Y, Tang R, Hu ZM, et al. Key Synaptic Pathology in Autism Spectrum Disorder: Genetic Mechanisms and Recent Advances. J Integr Neurosci. 2024;23(10):184. doi: 10.31083/j.jin2310184.

Rydzewska E, Dunn K, Cooper SA. Umbrella systematic review of systematic reviews and meta-analyses on comorbid physical conditions in people with autism spectrum disorder. Br J Psychiatry. 2021;218(1):10-19. doi: 10.1192/bjp.2020.167.

Kereszturi É. Database-assisted screening of autism spectrum disorder related gene set. Mol Brain. 2024;17(1):55. doi: 10.1186/s13041-024-01127-0.

Kim JY, Son MJ, Son CY, Radua J, Eisenhut M, Gressier F, Koyanagi A, Carvalho AF, Stubbs B, Solmi M, Rais TB, Lee KH, Kronbichler A, Dragioti E, Shin JI, Fusar-Poli P. Environmental risk factors and biomarkers for autism spectrum disorder: an umbrella review of the evidence. Lancet Psychiatry. 2019;6(7):590-600. doi: 10.1016/S2215-0366(19)30181-6.

Kılıçaslan F, Öz Ö, Mutlu MB. Investigation of chromosomal anomalies and copy number variations in children diagnosed with autism spectrum disorder by array CGH method. Int J Dev Neurosci. 2025;85(1):e10397. doi: 10.1002/jdn.10397.

Yu R, Hafeez R, Ibrahim M, Alonazi WB, et al. The complex interplay between autism spectrum disorder and gut microbiota in children: A comprehensive review. Behav Brain Res. 2024;473:115177. doi: 10.1016/j.bbr.2024.115177.

Gevezova M, Sbirkov Y, Sarafian V, et al. Autistic spectrum disorder (ASD) - Gene, molecular and pathway signatures linking systemic inflammation, mitochondrial dysfunction, transsynaptic signalling, and neurodevelopment. Brain Behav Immun Health. 2023;30:100646. doi: 10.1016/j.bbih.2023.100646.

Belyeu JR, Brand H, Wang Hi, et al. De novo structural mutation rates and gamete-of-origin biases revealed through genome sequencing of 2,396 families. Am J Hum Genet. 2021;108(4):597-607. doi: 10.1016/j.ajhg.2021.02.012.

Ali NMH, Chawner SJRA, Kushan-Wells L, et al. Comparison of autism domains across thirty rare variant genotypes. EBioMedicine. 2025;112:105521. doi: 10.1016/j.ebiom.2024.105521.

Klei L, McClain LL, Mahjani B, et al. How rare and common risk variation jointly affect liability for autism spectrum disorder. Mol Autism. 2021;12(1):66. doi: 10.1186/s13229-021-00466-2.

Havdahl A, Niarchou M, Starnawska A, et al. Genetic contributions to autism spectrum disorder. Psychol Med. 2021;51(13):2260-2273. doi: 10.1017/S0033291721000192.

Vicari S, Napoli E, Cordeddu V, et al. Copy number variants in autism spectrum disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2019;92:421-427. doi: 10.1016/j.pnpbp.2019.02.012.

Abedini SS, Akhavantabasi S, Liang Y et al. A critical review of the impact of candidate copy number variants on autism spectrum disorder. Mutat Res Rev Mutat Res. 2024;794:108509. doi: 10.1016/j.mrrev.2024.108509.

Villanueva R. Stem cell therapy for the treatment of psychiatric disorders: a real hope for the next decades. Front Psychiatry. 2025;15:1492415. doi: 10.3389/fpsyt.2024.1492415.

Kushima I, Aleksic B, Nakatochi M, et al. Comparative Analyses of Copy-Number Variation in Autism Spectrum Disorder and Schizophrenia Reveal Etiological Overlap and Biological Insights. Cell Rep. 2018;24(11):2838-2856. doi: 10.1016/j.celrep.2018.08.022.

Kushima I, Nakatochi M, Aleksic B, et al. Cross-Disorder Analysis of Genic and Regulatory Copy Number Variations in Bipolar Disorder, Schizophrenia, and Autism Spectrum Disorder. Biol Psychiatry. 2022;92(5):362-374. doi: 10.1016/j.biopsych.2022.04.003.

Vashisth S, Chahrour MH. Genomic strategies to untangle the etiology of autism: A primer. Autism Res. 2023;16(1):31-39. doi: 10.1002/aur.2844.

Al-Beltagi M, Saeed NK, Bediwy AS et al. Decoding the genetic landscape of autism: A comprehensive review. World J Clin Pediatr. 2024;13(3):98468. doi: 10.5409/wjcp.v13.i3.98468.

Huguet G, Ey E, Bourgeron T. The genetic landscapes of autism spectrum disorders. Annu Rev Genomics Hum Genet. 2013;14:191-213. doi: 10.1146/annurev-genom-091212-153431.

Baribeau D, Anagnostou E. Novel treatments for autism spectrum disorder based on genomics and systems biology. Phamendesrmacol Ther. 2022;230:107939. doi: 10.1016/j.pharmthera.2021.107939.

Ali NMH, Chawner SJRA, Kushan-Wells L, et al. Comparison of autism domains across thirty rare variant genotypes. EBioMedicine. 2025;112:105521. doi: 10.1016/j.ebiom.2024.105521.

Raznahan A, Won H, Glahn DC, et al. Convergence and Divergence of Rare Genetic Disorders on Brain Phenotypes: A Review. JAMA Psychiatry. 2022;79(8):818-828. doi: 10.1001/jamapsychiatry.2022.1450.

Molloy CJ, Quigley C, McNicholas Á, et al. A review of the cognitive impact of neurodevelopmental and neuropsychiatric associated copy number variants. Transl Psychiatry. 2023;13(1):116. doi: 10.1038/s41398-023-02421-6.

Mollon J, Almasy L, Jacquemont S, et al. The contribution of copy number variants to psychiatric symptoms and cognitive ability. Mol Psychiatry. 2023;28(4):1480-1493. doi: 10.1038/s41380-023-01978-4.

Rylaarsdam L, Guemez-Gamboa A. Genetic Causes and Modifiers of Autism Spectrum Disorder. Front Cell Neurosci. 2019;13:385. doi: 10.3389/fncel.2019.00385.

Genovese AC, Butler MG. Behavioral and Psychiatric Disorders in Syndromic Autism. Brain Sci. 2024;14(4):343. doi: 10.3390/brainsci14040343.

Grove J, Ripke S, Als TD, et al. Identification of common genetic risk variants for autism spectrum disorder. Nat Genet. 2019;51(3):431-444. doi: 10.1038/s41588-019-0344-8.

Matoba N, Liang D, Sun H, et al. Common genetic risk variants identified in the SPARK cohort support DDHD2 as a candidate risk gene for autism. Transl Psychiatry. 2020;10(1):265. doi: 10.1038/s41398-020-00953-9.

King EA, Davis JW, Degner JF. Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval. PLoS Genet. 2019;15(12):e1008489. doi: 10.1371/journal.pgen.1008489.

Jiang R, Huang W, Qiu X, et al. Unveiling promising drug targets for autism spectrum disorder: insights from genetics, transcriptomics, and proteomics. Brief Bioinform. 2024;25(4):bbae353. doi: 10.1093/bib/bbae353.

Loomes R, Hull L, Mandy WPL. What Is the Male-to-Female Ratio in Autism Spectrum Disorder? A Systematic Review and Meta-Analysis. J Am Acad Child Adolesc Psychiatry. 2017;56(6):466-474. doi: 10.1016/j.jaac.2017.03.013.

Kreiser NL, White SW. ASD in females: are we overstating the gender difference in diagnosis? Clin Child Fam Psychol Rev. 2014;17(1):67-84. doi: 10.1007/s10567-013-0148-9.

Leow KQ, Tonta MA, Lu J, Coleman HA, et al. Towards understanding sex differences in autism spectrum disorders. Brain Res. 2024;1833:148877. doi: 10.1016/j.brainres.2024.148877.

Ratto AB, Kenworthy L, Yerys BE, et al. What About the Girls? Sex-Based Differences in Autistic Traits and Adaptive Skills. J Autism Dev Disord. 2018;48(5):1698-1711. doi: 10.1007/s10803-017-3413-9.

Laine MA, Greiner EM, Shansky RM. Sex differences in the rodent medial prefrontal cortex - What Do and Don't we know? Neuropharmacology. 2024;248:109867. doi: 10.1016/j.neuropharm.2024.109867.

Ferri SL, Abel T, Brodkin ES. Sex Differences in Autism Spectrum Disorder: a Review. Curr Psychiatry Rep. 2018;20(2):9. doi: 10.1007/s11920-018-0874-2.

Mitra I, Tsang K, Ladd-Acosta C, et al. Correction: Pleiotropic Mechanisms Indicated for Sex Differences in Autism. PLoS Genet. 2017;13(6):e1006831. doi: 10.1371/journal.pgen.1006831. Erratum for: PLoS Genet. 2016;12(11):e1006425. doi: 10.1371/journal.pgen.1006425.

Pejhan S, Rastegar M. Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease. Biomolecules. 2021;11(1):75. doi: 10.3390/biom11010075.

Jiang CC, Lin LS, Long S, et al. Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications. Signal Transduct Target Ther. 2022;7(1):229. doi: 10.1038/s41392-022-01081-0.

Cast TP, Boesch DJ, Smyth K, et al. An Autism-Associated Mutation Impairs Neuroligin-4 Glycosylation and Enhances Excitatory Synaptic Transmission in Human Neurons. J Neurosci. 2021;41(3):392-407. doi: 10.1523/JNEUROSCI.0404-20.2020.

Nguyen TA, Wu K, Pandey S, et al. A Cluster of Autism-Associated Variants on X-Linked NLGN4X Functionally Resemble NLGN4Y.Neuron. 2020;106(5):759-768.e7. doi: 10.1016/j.neuron.2020.03.008.

Montanaro FAM, Mandarino A, Alesi V, Schwartz C, Sepulveda DJC, Skinner C, Friez M, Piccolo G, Novelli A, Zanni G, Dentici ML, Vicari S, Alfieri P. PTCHD1 gene mutation/deletion: the cognitive-behavioral phenotyping of four case reports. Front Psychiatry. 2024;14:1327802. doi: 10.3389/fpsyt.2023.1327802.

Shansky RM. Sex differences in mechanisms of disease. Genes Brain Behav. 2020;19(3):e12646. doi: 10.1111/gbb.12646.

de Giambattista C, Ventura P, Trerotoli P, et al. Sex Differences in Autism Spectrum Disorder: Focus on High Functioning Children and Adolescents. Front Psychiatry. 2021;12:539835. doi: 10.3389/fpsyt.2021.539835.

Werling DM. The role of sex-differential biology in risk for autism spectrum disorder. Biol Sex Differ. 2016;7:58. doi: 10.1186/s13293-016-0112-8.

Zhang Y, Li N, Li C, Zhang Z, Teng H, Wang Y, Zhao T, Shi L, Zhang K, Xia K, Li J, Sun Z. Genetic evidence of gender difference in autism spectrum disorder supports the female-protective effect. Transl Psychiatry. 2020;10(1):4. doi: 10.1038/s41398-020-0699-8.

Gao L, Zhang T, Zhang Y, et al. Sex Differences in Spatiotemporal Consistency and Effective Connectivity of the Precuneus in Autism Spectrum Disorder. J Autism Dev Disord. 2024;28. doi: 10.1007/s10803-024-06696-6.

Lee JK, Amaral DG, Solomon M, et al. Sex Differences in the Amygdala Resting-State Connectome of Children With Autism Spectrum Disorder. Biol Psychiatry Cogn Neurosci Neuroimaging. 2020;5(3):320-329. doi: 10.1016/j.bpsc.2019.08.004.

Reinhardt VP, Iosif AM, Libero L, et al. Understanding Hippocampal Development in Young Children With Autism Spectrum Disorder. J Am Acad Child Adolesc Psychiatry. 2020;59(9):1069-1079. doi: 10.1016/j.jaac.2019.08.008.

Velmeshev D, Schirmer L, Jung D, et al. Single-cell genomics identifies cell type-specific molecular changes in autism. Science. 2019;364(6441):685-689. doi: 10.1126/science.aav8130.

Willsey HR, Willsey AJ, Wang B, et al. Genomics, convergent neuroscience and progress in understanding autism spectrum disorder. Nat Rev Neurosci. 2022;23(6):323-341. doi: 10.1038/s41583-022-00576-7.

Trabzuni D, Ramasamy A, Imran S, et al. North American Brain Expression Consortium. Widespread sex differences in gene expression and splicing in the adult human brain. Nat Commun. 2013;4:2771. doi: 10.1038/ncomms3771.

Wingo AP, Liu Y, Gerasimov ES, et al. Sex differences in brain protein expression and disease. Nat Med. 2023;29(9):2224-2232. doi: 10.1038/s41591-023-02509-y.

Fass SB, Mulvey B, Chase R, et al. Relationship between sex biases in gene expression and sex biases in autism and Alzheimer's disease. Biol Sex Differ. 2024;15(1):47. doi: 10.1186/s13293-024-00622-2.

Simerly RB. Wired for reproduction: organization and development of sexually dimorphic circuits in the mammalian forebrain. Annu Rev Neurosci. 2002;25:507-36. doi: 10.1146/annurev.neuro.25.112701.142745.

Auyeung B, Baron-Cohen S, Ashwin E, Knickmeyer R, Taylor K, Hackett G. Fetal testosterone and autistic traits. Br J Psychol. 2009;100(Pt 1):1-22. doi: 10.1348/000712608X311731.

Baron-Cohen S, Tsompanidis A, Auyeung B et al. Foetal oestrogens and autism. Mol Psychiatry. 2020;25(11):2970-2978. doi: 10.1038/s41380-019-0454-9.

Cherskov A, Pohl A, Allison C, et al. Polycystic ovary syndrome and autism: A test of the prenatal sex steroid theory. Transl Psychiatry. 2018;8(1):136. doi: 10.1038/s41398-018-0186-7.

Kosidou K, Dalman C, Widman L, et al. Maternal polycystic ovary syndrome and the risk of autism spectrum disorders in the offspring: a population-based nationwide study in Sweden. Mol Psychiatry. 2016;21(10):1441-8. doi: 10.1038/mp.2015.183.

Jiang L, Tian L, Yuan J, Xu X, Qu F, Zhang R, Wang J. Associations Between Sex Hormone Levels and Autistic Traits in Infertile Patients With Polycystic Ovary Syndrome and Their Offspring. Front Endocrinol (Lausanne). 2022;12:789395. doi: 10.3389/fendo.2021.789395.

Genovese A, Butler MG. Clinical Assessment, Genetics, and Treatment Approaches in Autism Spectrum Disorder (ASD). Int J Mol Sci. 2020;21(13):4726. doi: 10.3390/ijms21134726.

Lintas C, Persico AM. Autistic phenotypes and genetic testing: state-of-the-art for the clinical geneticist. J Med Genet. 2009;46(1):1-8. doi: 10.1136/jmg.2008.060871.

Schaefer GB, Mendelsohn NJ; Professional Practice and Guidelines Committee. Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions. Genet Med. 2013;15(5):399-407. doi: 10.1038/gim.2013.32.

Waye MMY, Cheng HY. Genetics and epigenetics of autism: A Review. Psychiatry Clin Neurosci. 2018;72(4):228-244. doi: 10.1111/pcn.12606.

Genovese A, Butler MG. The Autism Spectrum: Behavioral, Psychiatric and Genetic Associations. Genes (Basel). 2023;14(3):677. doi: 10.3390/genes14030677.

Miyake N, Tsurusaki Y, Fukai R, et al. Molecular diagnosis of 405 individuals with autism spectrum disorder. Eur J Hum Genet. 2024;32(12):1551-1558. doi: 10.1038/s41431-023-01335-7.

Searles Quick VB, Wang B, State MW. Leveraging large genomic datasets to illuminate the pathobiology of autism spectrum disorders. Neuropsychopharmacology. 2021;46(1):55-69. doi: 10.1038/s41386-020-0768-y.

Woodbury-Smith M, Paterson AD, O'Connor I, et al. A genome-wide linkage study of autism spectrum disorder and the broad autism phenotype in extended pedigrees. J Neurodev Disord. 2018;10(1):20. doi: 10.1186/s11689-018-9238-9.

Sener EF, Canatan H, Ozkul Y. Recent Advances in Autism Spectrum Disorders: Applications of Whole Exome Sequencing Technology. Psychiatry Investig. 2016;13(3):255-64. doi: 10.4306/pi.2016.13.3.255.

Yuen T, Carter MT, Szatmari P, et al. Cost-effectiveness of Genome and Exome Sequencing in Children Diagnosed with Autism Spectrum Disorder. Appl Health Econ Health Policy. 2018;16(4):481-493. doi: 10.1007/s40258-018-0390-x.

Miyake N, Tsurusaki Y, Fukai R, et al. Molecular diagnosis of 405 individuals with autism spectrum disorder. Eur J Hum Genet. 2024;32(12):1551-1558. doi: 10.1038/s41431-023-01335-7.

Searles Quick VB, Wang B, et al . Leveraging large genomic datasets to illuminate the pathobiology of autism spectrum disorders. Neuropsychopharmacology. 2021;46(1):55-69. doi: 10.1038/s41386-020-0768-y.

Kimura H, Nakatochi M, Aleksic B, et al. Exome sequencing analysis of Japanese autism spectrum disorder case-control sample supports an increased burden of synaptic function-related genes. Transl Psychiatry. 2022;12(1):265. doi: 10.1038/s41398-022-02033-6.

Enriquez KD, Gupta AR, Hoffman EJ. Signaling Pathways and Sex Differential Processes in Autism Spectrum Disorder. Front Psychiatry. 2021;12:716673. doi: 10.3389/fpsyt.2021.716673.

Satterstrom FK, Kosmicki JA, Wang J, et al. Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism. Cell. 2020;180(3):568-584.e23. doi: 10.1016/j.cell.2019.12.036.

Feliciano P, Zhou X, Astrovskaya I, et al. Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes. NPJ Genom Med. 2019;4:19. doi: 10.1038/s41525-019-0093-8.

Shi X, Lu C, Corman A et al. Heterozygous deletion of the autism-associated gene CHD8 impairs synaptic function through widespread changes in gene expression and chromatin compaction. Am J Hum Genet. 2023;110(10):1750-1768. doi: 10.1016/j.ajhg.2023.09.004.

Blázquez A, Rodriguez-Revenga L, Alvarez-Mora MI et al. Clinical and genetic findings in autism spectrum disorders analyzed using exome sequencing. Front Psychiatry. 2025;16:1515793. doi: 10.3389/fpsyt.2025.1515793.

Brlek P, Bulić L, Bračić M et al. Implementing Whole Genome Sequencing (WGS) in Clinical Practice: Advantages, Challenges, and Future Perspectives. Cells. 2024;13(6):504. doi: 10.3390/cells13060504.

Bocher O, Willer CJ, Zeggini E. Unravelling the genetic architecture of human complex traits through whole genome sequencing. Nat Commun. 2023;14:3520 doi: 10.1038/s41467-023-39259.

Zhou J, Park CY, Theesfeld CL et al. Whole-genome deep-learning analysis identifies contribution of noncoding mutations to autism risk. Nat Genet. 2019;51(6):973-980. doi: 10.1038/s41588-019-0420-0.

Satam H, Joshi K, Mangrolia U et al. Next-Generation Sequencing Technology: Current Trends and Advancements. Biology (Basel). 2023;12(7):997. doi: 10.3390/biology12070997. Erratum in: Biology (Basel). 2024;13(5):286. doi: 10.3390/biology13050286.

Yoo H. Genetics of Autism Spectrum Disorder: Current Status and Possible Clinical Applications. Exp Neurobiol. 2015;24(4):257-72. doi: 10.5607/en.2015.24.4.257.

Qiu Z, Du A. Revisiting the genetic architecture of autism spectrum disorders in the genomic era: Insights from East Asian studies. Curr Opin Neurobiol. 2025;90:102936. doi: 10.1016/j.conb.2024.102936.

Furukawa S, Kushima I, Kato H, et al. Whole-genome sequencing analysis of Japanese autism spectrum disorder trios. Psychiatry Clin Neurosci. 2025;79(3):87-97. doi: 10.1111/pcn.13767.

Ćuk M, Unal B, Bagarić M, et al. Novel TBR1 c.1303C>T Variant Led to Diagnosis of Intellectual Developmental Disorder with Autism and Speech Delay: Application of Comprehensive Family-Based Whole-Genome Analysis. Genes (Basel). 2025;16(2):120. doi: 10.3390/genes16020120.

Ruzzo EK, Pérez-Cano L, Jung JY, et al. Inherited and De Novo Genetic Risk for Autism Impacts Shared Networks. Cell. 2019;178(4):850-866.e26. doi: 10.1016/j.cell.2019.07.015.

LaMantia AS. Polygenicity in a box: Copy number variants, neural circuit development, and neurodevelopmental disorders. Curr Opin Neurobiol. 2024;89:102917. doi: 10.1016/j.conb.2024.102917.

Bryers A, Hawkes CA, Parkin E, Dawson N. Progress towards understanding risk factor mechanisms in the development of autism spectrum disorders. Biochem Soc Trans. 2024;52(5):2047-2058. doi: 10.1042/BST20231004.

Leppa VM, Kravitz SN, Martin CL, et al. Rare Inherited and De Novo CNVs Reveal Complex Contributions to ASD Risk in Multiplex Families. Am J Hum Genet. 2016;99(3):540-554. doi: 10.1016/j.ajhg.2016.06.036.

Sebat J, Lakshmi B, Malhotra D, et al. Strong association of de novo copy number mutations with autism. Science. 2007;316(5823):445-9. doi: 10.1126/science.1138659.

Tamada K, Takumi T. Neurodevelopmental impact of CNV models in ASD: Recent advances and future directions. Curr Opin Neurobiol. 2025;92:103001. doi: 10.1016/j.conb.2025.103001.

Weiner DJ, Ling E, Erdin S, et al. Statistical and functional convergence of common and rare genetic influences on autism at chromosome 16p. Nat Genet. 2022;54(11):1630-1639. doi: 10.1038/s41588-022-01203-y.

Sandweiss AJ, Brandt VL, Zoghbi HY. Advances in understanding of Rett syndrome and MECP2 duplication syndrome: prospects for future therapies. Lancet Neurol. 2020 Aug;19(8):689-698. doi: 10.1016/S1474-4422(20)30217-9.

Vervoort L, Dierckxsens N, Pereboom Z, et al. 22q11.2 Low Copy Repeats Expanded in the Human Lineage. Front Genet. 2021;12:706641. doi: 10.3389/fgene.2021.706641.

Dinneen TJ, Ghrálaigh FN, Walsh R, et al. How does genetic variation modify ND-CNV phenotypes? Trends Genet. 2022;38(2):140-151. doi: 10.1016/j.tig.2021.07.006.

Tabbaa M, Knoll A, Levitt P. Mouse population genetics phenocopies heterogeneity of human Chd8 haploinsufficiency. Neuron. 2023;111(4):539-556.e5. doi: 10.1016/j.neuron.2023.01.009.

Min S, Kinnear C, D'Alessandro LCA, et al. Genetic Diagnosis and the Severity of Cardiovascular Phenotype in Patients With Elastin Arteriopathy. Circ Genom Precis Med. 2020;13(6):e002971. doi: 10.1161/CIRCGEN.120.002971.

Akula SK, Exposito-Alonso D, Walsh CA. Shaping the brain: The emergence of cortical structure and folding. Dev Cell. 2023;58(24):2836-2849. doi: 10.1016/j.devcel.2023.11.004.

Kushima I, Nakatochi M, Aleksic B, et al. Cross-Disorder Analysis of Genic and Regulatory Copy Number Variations in Bipolar Disorder, Schizophrenia, and Autism Spectrum Disorder. Biol Psychiatry. 2022;92(5):362-374. doi: 10.1016/j.biopsych.2022.04.003.

Feliciano P, Zhou X, Astrovskaya I, Turner TN, Wang T, Brueggeman L, Barnard R, Hsieh A, Snyder LG, Muzny DM, Sabo A; SPARK Consortium; Gibbs RA, Eichler EE, O'Roak BJ, Michaelson JJ, Volfovsky N, Shen Y, Chung WK. Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes. NPJ Genom Med. 2019;4:19. doi: 10.1038/s41525-019-0093-8.

Sener EF, Canatan H, Ozkul Y. Recent Advances in Autism Spectrum Disorders: Applications of Whole Exome Sequencing Technology. Psychiatry Investig. 2016;13(3):255-64. doi: 10.4306/pi.2016.13.3.255.

Trost B, Thiruvahindrapuram B, Chan AJS, et al. Genomic architecture of autism from comprehensive whole-genome sequence annotation. Cell. 2022;185(23):4409-4427.e18. doi: 10.1016/j.cell.2022.10.009.

Furukawa S, Kushima I, Kato H et al. Whole-genome sequencing analysis of Japanese autism spectrum disorder trios. Psychiatry Clin Neurosci. 2025;79(3):87-97. doi: 10.1111/pcn.13767.

Inbar-Feigenberg M, Choufani S, Butcher DT, et al. Basic concepts of epigenetics. Fertil Steril. 2013;99(3):607-15. doi: 10.1016/j.fertnstert.2013.01.117.

Yao TT, Chen L, Du Y, et al. MicroRNAs as Regulators, Biomarkers, and Therapeutic Targets in Autism Spectrum Disorder. Mol Neurobiol. 2025;62(4):5039-5056. doi: 10.1007/s12035-024-04582-x..

Yasuda Y, Matsumoto J, Miura K, et al. Genetics of autism spectrum disorders and future direction. J Hum Genet. 2023;68(3):193-197. doi: 10.1038/s10038-022-01076-3.

Csoka AB, El Kouhen N, Bennani S, et al . Roles of Epigenetics and Glial Cells in Drug-Induced Autism Spectrum Disorder. Biomolecules. 2024;14(4):437. doi: 10.3390/biom14040437.

Jin Z, Liu Y. DNA methylation in human diseases. Genes Dis. 2018;5(1):1-8. doi: 10.1016/j.gendis.2018.01.002.

Kimura R, Nakata M, Funabiki Y et al. An epigenetic biomarker for adult high-functioning autism spectrum disorder. Sci Rep. 2019;9(1):13662. doi: 10.1038/s41598-019-50250-9.

Li J, Xu X, Liu J, Zhang S, et al. Decoding microRNAs in autism spectrum disorder. Mol Ther Nucleic Acids. 2022;30:535-546. doi: 10.1016/j.omtn.2022.11.005.

Beygo J, Grosser C, Kaya S et al. Common genetic variation in the Angelman syndrome imprinting centre affects the imprinting of chromosome 15. Eur J Hum Genet. 2020;28(6):835-839. doi: 10.1038/s41431-020-0595-y.

Ryan NM, Heron EA. Evidence for parent-of-origin effects in autism spectrum disorder: a narrative review. J Appl Genet. 2023;64(2):303-317. doi: 10.1007/s13353-022-00742-8.

Wang L, Wang B, Wu C, et al. Autism Spectrum Disorder: Neurodevelopmental Risk Factors, Biological Mechanism, and Precision Therapy. Int J Mol Sci. 2023;24(3):1819. doi: 10.3390/ijms24031819.

Grafodatskaya D, Chung B, Szatmari P, Weksberg R. Autism spectrum disorders and epigenetics. J Am Acad Child Adolesc Psychiatry. 2010;49(8):794-809. doi: 10.1016/j.jaac.2010.05.005.

Siniscalco D, Cirillo A, Bradstreet JJ, Antonucci N. Epigenetic findings in autism: new perspectives for therapy. Int J Environ Res Public Health. 2013;10(9):4261-73. doi: 10.3390/ijerph10094261.

Huang F, Zhou T, Yao X, Yi J, Zhou F, Long Z, Hou X, Wang C, Chen Z, Jiang H. miRNA profiling in autism spectrum disorder in China. Genom Data. 2015 Aug 12;6:108-9. doi: 10.1016/j.gdata.2015.08.006.

Miyake K, Hirasawa T, Koide T, et al. Epigenetics in autism and other neurodevelopmental diseases. Adv Exp Med Biol. 2012;724:91-8. doi: 10.1007/978-1-4614-0653-2_7.

Abdul QA, Yu BP, Chung HY, et al. Epigenetic modifications of gene expression by lifestyle and environment. Arch Pharm Res. 2017;40(11):1219-1237. doi: 10.1007/s12272-017-0973-3.

Blum K, Bowirrat A, Sunder K, et al. Dopamine Dysregulation in Reward and Autism Spectrum Disorder. Brain Sci. 2024;14(7):733. doi: 10.3390/brainsci14070733.

Qin L, Ma K, Wang ZJ, et al. Social deficits in Shank3-deficient mouse models of autism are rescued by histone deacetylase (HDAC) inhibition. Nat Neurosci.;21(4):564-575. doi: 10.1038/s41593-018-0110-8.

Gurtan AM, Sharp PA. The role of miRNAs in regulating gene expression networks. J Mol Biol. 2013;425(19):3582-600. doi: 10.1016/j.jmb.2013.03.007.

Kim JY, Kim W, Lee KH. The role of microRNAs in the molecular link between circadian rhythm and autism spectrum disorder. Anim Cells Syst (Seoul). 2023;27(1):38-52. doi: 10.1080/19768354.2023.2180535.

Cao DD, Li L, Chan WY. MicroRNAs: Key Regulators in the Central Nervous System and Their Implication in Neurological Diseases. Int J Mol Sci. 2016;17(6):842. doi: 10.3390/ijms17060842.

Lang MF, Shi Y. Dynamic Roles of microRNAs in Neurogenesis. Front Neurosci. 2012;6:71. doi: 10.3389/fnins.2012.00071.

Khoodoruth MAS, Khoodoruth WNC, Uroos M, et al. Diagnostic and mechanistic roles of MicroRNAs in neurodevelopmental & neurodegenerative disorders. Neurobiol Dis. 2024;202:106717. doi: 10.1016/j.nbd.2024.106717.

Tsujimura K, Shiohama T, Takahashi E. microRNA Biology on Brain Development and Neuroimaging Approach. Brain Sci. 2022;12(10):1366. doi: 10.3390/brainsci12101366.

Yao Q, Chen Y, Zhou X. The roles of microRNAs in epigenetic regulation. Curr Opin Chem Biol. 2019;51:11-17. doi: 10.1016/j.cbpa.2019.01.024.

Hu Y, Ehli EA, Boomsma DI. MicroRNAs as biomarkers for psychiatric disorders with a focus on autism spectrum disorder: Current progress in genetic association studies, expression profiling, and translational research. Autism Res. 2017;10(7):1184-1203. doi: 10.1002/aur.1789.

Parkins EV, Gross C. Small Differences and Big Changes: The Many Variables of MicroRNA Expression and Function in the Brain. J Neurosci. 2024;44(32):e0365242024. doi: 10.1523/JNEUROSCI.0365-24.2024.

Ander BP, Barger N, Stamova B, et al. Atypical miRNA expression in temporal cortex associated with dysregulation of immune, cell cycle, and other pathways in autism spectrum disorders. Mol Autism. 2015:37. doi: 10.1186/s13229-015-0029-9.

Yu D, Jiao X, Cao T, et al. Serum miRNA expression profiling reveals miR-486-3p may play a significant role in the development of autism by targeting ARID1B. Neuroreport. 2018;29(17):1431-1436. doi: 10.1097/WNR.0000000000001107.

Sarachana T, Zhou R, Chen G, et al. Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell lines. Genome Med. 2010;2(4):23. doi: 10.1186/gm144.

Hicks SD, Carpenter RL, Wagner KE, et al. MicroRNA Differentiates Children With Autism From Peers With Typical and Atypical Development. J Am Acad Child Adolesc Psychiatry. 2020;59(2):296-308. doi: 10.1016/j.jaac.2019.03.017.

Kaysheva AL, Isaeva AI, Pleshakova TO, et al. Detection of Circulating Serum microRNA/Protein Complexes in ASD Using Functionalized Chips for an Atomic Force Microscope. Molecules. 2021;26(19):5979. doi: 10.3390/molecules26195979.

Hicks SD, Middleton FA. A Comparative Review of microRNA Expression Patterns in Autism Spectrum Disorder. Front Psychiatry. 2016;7:176. doi: 10.3389/fpsyt.2016.00176.

Mirabella F, Randazzo M, Rinaldi A, et al. Glycosylation Pathways Targeted by Deregulated miRNAs in Autism Spectrum Disorder. Int J Mol Sci. 2025;26(2):783. doi: 10.3390/ijms26020783.

Hosokawa R, Yoshino Y, Funahashi Y et al. MiR-15b-5p Expression in the Peripheral Blood: A Potential Diagnostic Biomarker of Autism Spectrum Disorder. Brain Sci. 2022;13(1):27. doi: 10.3390/brainsci13010027.

Ozkul Y, Taheri S, Bayram KK, et al. A heritable profile of six miRNAs in autistic patients and mouse models. Sci Rep. 2020;10(1):9011. doi: 10.1038/s41598-020-65847-8.

Kichukova T, Petrov V, Popov N, et al. Identification of serum microRNA signatures associated with autism spectrum disorder as promising candidate biomarkers. Heliyon. 2021;7(7):e07462. doi: 10.1016/j.heliyon.2021.e07462.

Jyonouchi H, Geng L, Toruner GA, et al. Serum microRNAs in ASD: Association With Monocyte Cytokine Profiles and Mitochondrial Respiration. Front Psychiatry. 2019;10:614. doi: 10.3389/fpsyt.2019.00614.

Nt P, Ds M, Mm N, In M, Ti V. Investigation of Circulating Serum MicroRNA-328-3p and MicroRNA-3135a Expression as Promising Novel Biomarkers for Autism Spectrum Disorder. Balkan J Med Genet. 2018 Dec 31;21(2):5-12.

Ren J, Bai Y, Gao J et al. Diagnostic Value of Serum miR-499a-5p in Chinese Children with Autism Spectrum Disorders. J Mol Neurosci. 2025;75(1):8. doi: 10.1007/s12031-024-02296-2.

Shen L, Lin Y, Sun Z, et al. Knowledge-Guided Bioinformatics Model for Identifying Autism Spectrum Disorder Diagnostic MicroRNA Biomarkers. Sci Rep. 2016;6:39663. doi: 10.1038/srep39663.

Gholamalizadeh H, Amiri-Shahri M, Rasouli F, Ansari A, Baradaran Rahimi V, Reza Askari V. DNA Methylation in Autism Spectrum Disorders: Biomarker or Pharmacological Target? Brain Sci. 2024;14(8):737. doi: 10.3390/brainsci14080737.

Cheung WA, Shao X, Morin A, et al. Functional variation in allelic methylomes underscores a strong genetic contribution and reveals novel epigenetic alterations in the human epigenome. Genome Biol. 2017;18(1):50. doi: 10.1186/s13059-017-1173-7. Erratum in: Genome Biol. 2019;20(1):89. doi: 10.1186/s13059-019-1702-7.

Kuodza GE, Kawai R, LaSalle JM. Intercontinental insights into autism spectrum disorder: a synthesis of environmental influences and DNA methylation. Environ Epigenet. 2024;10(1):dvae023. doi: 10.1093/eep/dvae023.

LaSalle JM. Epigenomic signatures reveal mechanistic clues and predictive markers for autism spectrum disorder. Mol Psychiatry. 2023;28(5):1890-1901. doi: 10.1038/s41380-022-01917-9.

Moore LD, Le T, Fan G. DNA methylation and its basic function. Neuropsychopharmacology. 2013;38(1):23-38. doi: 10.1038/npp.2012.112.

Tremblay MW, Jiang YH. DNA Methylation and Susceptibility to Autism Spectrum Disorder. Annu Rev Med. 2019;70:151-166. doi: 10.1146/annurev-med-120417-091431.

Christian DL, Wu DY, Martin JR, et al. DNMT3A Haploinsufficiency Results in Behavioral Deficits and Global Epigenomic Dysregulation Shared across Neurodevelopmental Disorders. Cell Rep. 2020;33(8):108416. doi: 10.1016/j.celrep.2020.108416.

Herrera ML, Paraíso-Luna J, Bustos-Martínez I, Barco Á. Targeting epigenetic dysregulation

in autism spectrum disorders. Trends Mol Med. 2024;30(11):1028-1046. doi:10.1016/j.molmed.2024.06.004.

Liu XS, Wu H, Krzisch M, et al. Rescue of Fragile X Syndrome Neurons by DNA Methylation Editing of the FMR1 Gene. Cell. 2018;172(5):979-992.e6. doi: 10.1016/j.cell.2018.01.012.

Zhu L, Wang X, Li XL, Towers A, et al.Epigenetic dysregulation of SHANK3 in brain tissues from individuals with autism spectrum disorders. Hum Mol Genet. 2014;23(6):1563-78. doi: 10.1093/hmg/ddt547.

Garrido N, Cruz F, Egea RR, et al. Sperm DNA methylation epimutation biomarker for paternal offspring autism susceptibility. Clin Epigenetics. 2021;13(1):6. doi: 10.1186/s13148-020-00995-2.

Feinberg JI, Schrott R, Ladd-Acosta C, et al. Epigenetic changes in sperm are associated with paternal and child quantitative autistic traits in an autism-enriched cohort. Mol Psychiatry. 2024;29(1):43-53. doi: 10.1038/s41380-023-02046-7.

Gallo R, Stoccoro A, Cagiano R, et al. Correlation among maternal risk factors, gene methylation and disease severity in females with autism spectrum disorder. Epigenomics. 2022;14(4):175-185. doi: 10.2217/epi-2021-0494.

Zhao Y, Zhou C, Yu H, et al. Association between the methylation of six apoptosis associated genes with autism spectrum disorder. Mol Med Rep. 2018;18(5):4629-4634. doi: 10.3892/mmr.2018.9473.

Abdolmaleky HM, Zhou JR, Thiagalingam S. Cataloging recent advances in epigenetic alterations in major mental disorders and autism. Epigenomics. 2021;13(15):1231-1245. doi: 10.2217/epi-2021-0074.

Vlasakova K, Tsuchiya T, Garfinkel IN, et al. Performance of biomarkers NF-L, NSE, Tau and GFAP in blood and cerebrospinal fluid in rat for the detection of nervous system injury. Front Neurosci. 2024;17:1285359. doi: 10.3389/fnins.2023.1285359.

Uddin LQ, Dajani DR, Voorhies W, et al. Progress and roadblocks in the search for brain-based biomarkers of autism and attention-deficit/hyperactivity disorder. Transl Psychiatry. 2017;7(8):e1218. doi: 10.1038/tp.2017.164.

Wakefield JC. Diagnostic Issues and Controversies in DSM-5: Return of the False Positives Problem. Annu Rev Clin Psychol. 2016;12:105-32. doi: 10.1146/annurev-clinpsy-032814-112800.

Krämer J, Beer M, Bode H, et al . Two Novel Compound Heterozygous Mutations in the TRAPPC9 Gene Reveal a Connection of Non-syndromic Intellectual Disability and Autism Spectrum Disorder. Front Genet. 2021;11:972. doi: 10.3389/fgene.2020.00972.

Jiang HY, Xu LL, Shao L, et al. Maternal infection during pregnancy and risk of autism spectrum disorders: A systematic review and meta-analysis. Brain Behav Immun. 2016;58:165-172. doi: 10.1016/j.bbi.2016.06.005.

de Sena Barbosa MG, Vilela de Souza RL, et al. Biomarkers for autism spectrum disorder: a short review. Ann Med Surg (Lond). 2024;86(12):7227-7231.

Frye RE, Vassall S, Kaur G, Lewis C, Karim M, Rossignol D. Emerging biomarkers in autism spectrum disorder: a systematic review. Ann Transl Med. 2019;7(23):792. doi: 10.21037/atm.2019.11.53.

Kong X, Liu J, Cetinbas M, et al. New and Preliminary Evidence on Altered Oral and Gut Microbiota in Individuals with Autism Spectrum Disorder (ASD): Implications for ASD Diagnosis and Subtyping Based on Microbial Biomarkers. Nutrients. 2019;11(9):2128. doi: 10.3390/nu11092128.

Patel J, Lukkes JL, Shekhar A. Overview of genetic models of autism spectrum disorders. Prog Brain Res. 2018;241:1-36. doi: 10.1016/bs.pbr.2018.10.002.

Silverman JL, Thurm A, Ethridge SB, et al. Reconsidering animal models used to study autism spectrum disorder: Current state and optimizing future. Genes Brain Behav. 2022;21(5):e12803. doi: 10.1111/gbb.12803.

Fard YA, Sadeghi EN, Pajoohesh Z et al. Epigenetic underpinnings of the autistic mind: Histone modifications and prefrontal excitation/inhibition imbalance. Am J Med Genet B Neuropsychiatr Genet. 2024;195(8):e32986. doi: 10.1002/ajmg.b.32986.

Kazdoba TM, Leach PT, Yang M, et al. Translational Mouse Models of Autism: Advancing Toward Pharmacological Therapeutics. Curr Top Behav Neurosci.2016;28:1-52. doi: 10.1007/7854_2015_5003.

Narvaiz DA, Nolan SO, Smith GD, et al. Rapamycin improves social and stereotypic behavior abnormalities induced by pre-mitotic neuronal subset specific Pten deletion. Genes Brain Behav. 2023;22(4):e12854. doi: 10.1111/gbb.12854.

Thomas SD, Jha NK, Ojha S, et al. mTOR Signaling Disruption and Its Association with the Development of Autism Spectrum Disorder. Molecules. 2023;28(4):1889. doi: 10.3390/molecules28041889.

Thomas SD, Jha NK, Ojha S, Sadek B. mTOR Signaling Disruption and Its Association with the Development of Autism Spectrum Disorder. Molecules. 2023;28(4):1889. doi: 10.3390/molecules28041889.

Hamilton SM, Green JR, Veeraragavan S, Yuva L, McCoy A, Wu Y, Warren J, Little L, Ji D, Cui X, Weinstein E, Paylor R. Fmr1 and Nlgn3 knockout rats: novel tools for investigating autism spectrum disorders. Behav Neurosci. 2014;128(2):103-9.

Meshalkina DA, N Kizlyk M, V Kysil E, et al. Zebrafish models of autism spectrum disorder. Exp Neurol. 2018;299(Pt A):207-216. doi: 10.1016/j.expneurol.2017.02.004.

Ornoy A, Echefu B, Becker M. Animal Models of Autistic-like Behavior in Rodents: A Scoping Review and Call for a Comprehensive Scoring System. Int J Mol Sci. 2024;25(19):10469. doi: 10.3390/ijms251910469.

Ornoy, A. Echefu, B. Becker, M. Valproic Acid in Pregnancy Revisited: Neurobehavioral, Biochemical and Molecular Changes Affecting the Embryo and Fetus in Humans and in Animals: A Narrative Review. Int. J. Mol. Sci. 2024, 25, 390. doi.org/10.3390/ijms25010390

Dana H, Bayramov KK, Delibaşı N et al. Disregulation of Autophagy in the Transgenerational Cc2d1a Mouse Model of Autism. Neuromolecular Med. 2020;22(2):239-249. doi: 10.1007/s12017-019-08579x.

Sener EF, Dana H, Tahtasakal R et al. Heterozygous Cc2d1a mice show sex-dependent changes in the Beclin-1/p62 ratio with impaired prefrontal cortex and hippocampal autophagy. Prog Neuropsychopharmacol Biol Psychiatry. 2023;125:110764. doi: 10.1016/j.pnpbp.2023.110764.

Manzini MC, Xiong L, Shaheen R et al. CC2D1A regulates human intellectual and social function as well as NF-κB signaling homeostasis. Cell Rep. 2014 ;8(3):647-55. doi: 10.1016/j.celrep.2014.06.039.

Bhattacharya A, Parlanti P, Cavallo L et al. A novel framework for functional annotation of variants of uncertain significance in ID/ASD risk gene CC2D1A. Hum Mol Genet. 2024;33(14):1229-1240. doi: 10.1093/hmg/ddae070.

Yi S, Tang X, Zhang Q et al. A nonsense CC2D1A variant is associated with congenital anomalies, motor delay, hypotonia, and slight deformities. Heliyon. 2024;10(6):e27946. doi: 10.1016/j.heliyon.2024.e27946.

Sener EF, Onal MG, Dal F et al. Novel alterations of CC2D1A as a candidate gene in a Turkish sample of patients with autism spectrum disorder. Int J Neurosci. 2022 Nov;132(11):1072-1079. doi: 10.1080/00207454.2020.1860968.

Zamarbide M, Mossa A, Muñoz-Llancao P et al. Male-Specific cAMP Signaling in the Hippocampus Controls Spatial Memory Deficits in a Mouse Model of Autism and Intellectual Disability. Biol Psychiatry. 2019;85(9):760-768. doi: 10.1016/j.biopsych.2018.12.013.

Mossa A, Manzini MC. Molecular causes of sex-specific deficits in rodent models of neurodevelopmental disorders. J Neurosci Res. 2021;99(1):37-56. doi: 10.1002/jnr.24577.

Ornoy A, Echefu B, Becker M. Valproic Acid in Pregnancy Revisited: Neurobehavioral, Biochemical and Molecular Changes Affecting the Embryo and Fetus in Humans and in Animals: A Narrative Review. Int J Mol Sci. 2023;25(1):390. doi: 10.3390/ijms25010390.

Kurahashi H, Kunisawa K, Tanaka KF, et al. Autism spectrum disorder-like behaviors induced by hyper-glutamatergic NMDA receptor signaling through hypo-serotonergic 5-HT1A receptor signaling in the prefrontal cortex in mice exposed to prenatal valproic acid. Neuropsychopharmacology. 2025;50(5):739-750. doi: 10.1038/s41386-024-02004-z.

Ghahremani R, Mohammadkhani R, Salehi I et al. Sex Differences in Spatial Learning and Memory in Valproic Acid Rat Model of Autism: Possible Beneficial Role of Exercise Interventions. Front Behav Neurosci. 2022 Apr;16:869792. doi: 10.3389/fnbeh.2022.869792.

Szatmari P, Liu XQ, Goldberg J et al. Sex differences in repetitive stereotyped behaviors in autism: implications for genetic liability. Am J Med Genet B Neuropsychiatr Genet. 2012;159B(1):5-12. doi: 10.1002/ajmg.b.31238.

Beggiato A, Peyre H, Maruani A et al. Gender differences in autism spectrum disorders: Divergence among specific core symptoms. Autism Res. 2017;10(4):680-689. doi: 10.1002/aur.1715.

Feleke R, Jazayeri D, Abouzeid M, et al. Integrative genomics reveals pathogenic mediator of valproate-induced neurodevelopmental disability. Brain. 2022 Nov;145(11):3832-3842. doi: 10.1093/brain/awac296.

Guerra M, Medici V, Weatheritt R, et al. Fetal exposure to valproic acid dysregulates the expression of autism-linked genes in the developing cerebellum. Transl Psychiatry. 2023;13(1):114. doi: 10.1038/s41398-023-02391-9.

Mattheisen M, Grove J, Als TD, et al. Identification of shared and differentiating genetic architecture for autism spectrum disorder, attention-deficit hyperactivity disorder and case subgroups. Nat Genet. 2022;54(10):1470-1478. doi: 10.1038/s41588-022-01171-3.

Ramaswami G, Won H, Gandal MJ, Haney J, Wang JC, Wong CCY, Sun W, Prabhakar S, Mill J, Geschwind DH. Integrative genomics identifies a convergent molecular subtype that links epigenomic with transcriptomic differences in autism. Nat Commun. 2020 Sep 25;11(1):4873. doi: 10.1038/s41467-020-18526-1.